SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib

被引:7
|
作者
Ru, Chen [1 ,2 ]
Qian, Tangliang [1 ,2 ]
Liu, Xiaoping [2 ]
Wang, Chaoxin [2 ]
Li, Weizhong [3 ]
Hou, Xiujuan [2 ]
Li, Chen [3 ]
机构
[1] Beijing Univ Chinese Med, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Dongfang Hosp, Dept Rheumatol, Beijing, Peoples R China
[3] Beijing Univ Chinese Med, Fangshan Hosp, Dept Rheumatol, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
SAPHO syndrome; Takayasu arteritis; tofacitinib;
D O I
10.1111/1756-185X.14628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAPHO syndrome is an autoinflammatory disease with a variety of clinical manifestations, which may be accompanied by other systemic inflammatory diseases in addition to the typical manifestations of common synovitis, acne, pustulosis, hyperostosis, and osteitis. Here, we report the first case of SAPHO syndrome combined with Takayasu arteritis.
引用
收藏
页码:1381 / 1383
页数:3
相关论文
共 50 条
  • [21] Tofacitinib: a successful treatment option for SAPHO syndrome
    Sarikaya Solak, Sezgi
    Yelgen Ilyas, Hande
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (05) : 671 - 674
  • [22] Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
    Della Rossa, A
    Tavoni, A
    Merlini, G
    Baldini, C
    Sebastiani, M
    Lombardi, M
    Neglia, D
    Bombardieri, S
    RHEUMATOLOGY, 2005, 44 (08) : 1074 - 1075
  • [23] Primary aortoduodenal fistula treated successfully with surgery in a patient with Takayasu's arteritis - Case report
    Shindo, S
    Suzuki, O
    Kamiya, K
    Tada, Y
    INTERNATIONAL ANGIOLOGY, 1999, 18 (03) : 244 - 246
  • [24] Alopecia universalis successfully treated with tofacitinib
    McKesey, Jacqueline
    Blankenship, D. Winslow
    Jamison, Megan
    DeWitt, Christine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB38 - AB38
  • [25] Tofacitinib for the treatment of refractory Takayasu's arteritis: description of 2 cases
    Palermo, A.
    Marvisi, C.
    Casali, M.
    Pipitone, N.
    Muratore, F.
    Salvarani, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : S234 - S235
  • [26] Extended-release tofacitinib improves refractory Takayasu's arteritis
    Wang, C-R
    Tsai, Y-S
    Liu, Y-W
    Li, Y-H
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2022, 51 (01) : 72 - 75
  • [27] A Case of SAPHO Syndrome With Diffuse Sclerosing Osteomyelitis of the Mandible Treated Successfully With Prednisolone and Bisphosphonate
    Hatano, Hiroko
    Shigeishi, Hideo
    Higashikawa, Koichiro
    Shimasue, Hiroshi
    Nishi, Hiromi
    Oiwa, Hiroshi
    Shindo, Hajime
    Takechi, Masaaki
    Ohge, Hiroki
    Kamata, Nobuyuki
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2012, 70 (03) : 626 - 631
  • [28] SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate
    Vekic, D.
    Woods, J.
    Cains, G. D.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2017, 58 : 98 - 98
  • [29] A Case Report of Refractory UC With Associated SAPHO Treated With Tofacitinib
    Kim, Bryan J.
    Beck, Kendall R.
    Dietz, Brett
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2161 - S2161
  • [30] Ulcerated necrobiosis lipoidica successfully treated with tofacitinib
    Janssen, Sarah
    Jansen, Theresa M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : 739 - 741